Your browser doesn't support javascript.
loading
A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers.
Wu, C; Mikhail, S; Wei, L; Timmers, C; Tahiri, S; Neal, A; Walker, J; El-Dika, S; Blazer, M; Rock, J; Clark, D J; Yang, X; Chen, J L; Liu, J; Knopp, M V; Bekaii-Saab, T.
Afiliação
  • Wu C; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, OH 43210, USA.
  • Mikhail S; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, OH 43210, USA.
  • Wei L; Center for Biostatistics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
  • Timmers C; The Ohio State University Comprehensive Cancer Center, Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, OH 43210, USA.
  • Tahiri S; The Ohio State University Comprehensive Cancer Center, Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, OH 43210, USA.
  • Neal A; The Ohio State University Comprehensive Cancer Center, Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, OH 43210, USA.
  • Walker J; Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • El-Dika S; Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Blazer M; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Rock J; Anatomic Pathology Laboratory, Mercy Anderson Hospital, Cincinnati, OH 43210, USA.
  • Clark DJ; Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Yang X; Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Chen JL; Division of Medical Oncology, Departments of Biomedical Informatics and Internal Medicine, The Ohio State University Comprehensive Cancer Center, Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, OH 43210, USA.
  • Liu J; Department of Pathology, Beaumont Medical Center, Grosse Pointe, MI, USA.
  • Knopp MV; Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Bekaii-Saab T; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, OH 43210, USA.
Br J Cancer ; 113(2): 220-5, 2015 Jul 14.
Article em En | MEDLINE | ID: mdl-26151457
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article